EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms

Giorgia Rutigliani iD, Tzu-Wen L Cross, Erica de Jong, Emily S Glover, Ivan D Mendoza, Mojisola Adisa, Keigo Tomoo, Xinyi Zhou, Richard D Mattes

Obesity Reviews · 2026

DOI: 10.1111/obr.70148 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Obesity Reviews, 2026. Verfasst von Giorgia Rutigliani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Science, Purdue University, West Lafayette, Indiana, USA. Hauptthemen laut MEDLINE: Weight Loss, Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Anti-Obesity Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 232 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GLP‐1 receptor agonist medications have the potential to promote marked weight loss, but maximal and sustained benefit may be compromised by poor compliance and cessation of use. Development of next‐generation medications that address current obstacles to effective use and development of effective adjunct treatments will benefit from better characterization of their mechanisms of action. This narrative review critically assesses eight purported mechanisms including modulation of appetite, chemosensory function, cravings/aversions, food noise, gastric emptying, the microbiome, incretin activity, and energy expenditure. Current evidence does not support a single dominant mechanism; a combination of subtle effects may underlie the efficacy of these medications. However, as experience with these medications and methods to assess their effects grows, it should be possible to better determine the relative importance of these and possibly other mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Weight LossGlucagon-Like Peptide-1 Receptor AgonistsObesityAnti-Obesity AgentsHumansGastric EmptyingAppetiteEnergy MetabolismGlucagon-Like Peptide-1 ReceptorIncretins

Stichwörter der Autor:innen

appetitefood cravingsfood noisegastric emptyingmicrobiomesensory function

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsAnti-Obesity AgentsGlucagon-Like Peptide-1 ReceptorIncretins

Autor:innen und Institutionen

  • Department of Nutrition Science, Purdue University, West Lafayette, Indiana, USA.
  • Department of Food Science, Purdue University, West Lafayette, Indiana, USA.
  • Department of Human Development and Family Science, Purdue University, West Lafayette, Indiana, USA.

ORCID-Profile: Giorgia Rutigliani

Zitieren

APA

Rutigliani, G., Cross, T. L., de Jong, E., Glover, E. S., Mendoza, I. D., Adisa, M., Tomoo, K., Zhou, X., & Mattes, R. D. (2026). GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms. Obesity Reviews. https://doi.org/10.1111/obr.70148

Vancouver

Rutigliani G, Cross TL, de Jong E, Glover ES, Mendoza ID, Adisa M, et al. GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms. Obesity Reviews. 2026. doi:10.1111/obr.70148

BibTeX
@article{Rutigliani2026,
  author = {Rutigliani, Giorgia and Cross, Tzu-Wen L and de Jong, Erica and Glover, Emily S and Mendoza, Ivan D and Adisa, Mojisola and Tomoo, Keigo and Zhou, Xinyi and Mattes, Richard D},
  title = {GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms},
  journal = {Obesity Reviews},
  year = {2026},
  doi = {10.1111/obr.70148}
}
Kostenlos starten →